GUSELKUMAB IMPROVES DACTYLITIS IN PSA PATIENTS WITH INADEQUATE RESPONSE TO TNFI: DATA FROM THE PHASE 3B COSMOS TRIAL - Marzo-Ortega, H.; Theander, E.; Neuhold, M.; Bergmans, P.; Shawi, M.; Perate, M.; Contre, C.; Mcinnes, I.; Schett, Georg (ANNALS OF THE RHEUMATIC DISEASES, 2022)
CRIS-Team WoS Importer:2022-11-04